Cardiff Oncology, Inc. earnings per share and revenue

CRDF earnings per share for the last quarter are -0.26 USD whereas the estimation was -0.25 USD which accounts for -5.05% surprise. Company revenue for the same period amounts to 163.00 k USD despite the estimated figure of 58.75 k USD. Estimated earnings per share for the next quarter are -0.27 USD, and revenue is expected to reach 80.00 k USD. Also watch annual changes over time to get a bigger picture of CRDF earnings per share and revenue dynamics.